Advertisement

Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: Evidence for a second flare

  • Jeffrey L. Deaton
  • Paula Bauguess
  • Carolyn S. Huffman
  • Kathleen A. Miller
Clinical Assisted Reproduction

Abstract

Purpose: Our purpose was to determine the pituitary response to minidose follicular-phase GnRHa and see if a second flare can be achieved.

Method: A prospective, consecutive series of 12 couples with tubal-factor infertility underwent 14 cycles of minidose GnRHa. Women were given a 25- or 50-µg dose of leuprolide acetate (LA) on cycle days 2 and 5. On cycle days 3 and 4 no LA was given but 2 ampoules of pure follicle stimulating hormone (FSH) was administered. Beginning day 6, a combination of LA and FSH was administered.

Results: Following a dose of only 25µg of LA on cycle day 2, mean FSH, LH, and E2 levels were significantly elevated over the baseline levels. Following no LA on cycle day 3 or 4, a repeat dose of 25µg LA caused a second flare of LH and E2 on cycle day 6. Of the 14 cycles, 6 were canceled because of poor stimulation. Two of the eight patients who underwent retrieval delivered a live birth.

Conclusions: This is the first study to examine both the pituitary response and the recovery time from minidose follicular-phase GnRHa. An extremely small dose of LA is needed to cause a pituitary flare of gonadotropins. Following a flare from 25µg of LA on cycle day 2, the pituitary is able to recover and respond with a repeat flare on cycle day 5.

Key words

in vitro fertilization minidose gonadotropin releasing hormone agonist ovulation induction pituitary flare pituitary recovery 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynh D: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51:455–459PubMedGoogle Scholar
  2. 2.
    Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu H-C, Rosenwaks Z: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292–297PubMedGoogle Scholar
  3. 3.
    Stone BA, Serafini PC, Quinn K, Quinn P, Kerin JF, Marrs R P: Gonadotropin and estradiol levels during ovarian stimulation in women treated with leuprolide acetate. Obstet Gynecol 1989;73:990–995PubMedGoogle Scholar
  4. 4.
    Sathanandan M, Warnes GM, Kirby CA, Petrucco OM, Matthews CD: Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer. Fertil Steril 1989;51:998–1006PubMedGoogle Scholar
  5. 5.
    Garcia JE, Padilla SL, Bayati J, Baramki TA: Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: A better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302–305PubMedGoogle Scholar
  6. 6.
    Maroulis GB, Emery M, Verkauf BS, Saphier A, Bernhisel M, Yeko TR: Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization. Fertil Steril 1991;55:1157–1164PubMedGoogle Scholar
  7. 7.
    Pellicer A, Simón C, Miró F, Castellví RM, Ruiz A, Ruiz M, Pérez M, Bonilla-Musoles F: Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle. Hum Reprod 1989;4:285–289PubMedGoogle Scholar
  8. 8.
    Owen EJ, Davies MC, Kingsland CR, Jacobs HS, Mason BA: The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles. Hum Reprod 1989;4:749–753PubMedGoogle Scholar
  9. 9.
    Padilla SL, Smith RD, Garcia JE: The Lupron screening test: Tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization. Fertil Steril 1991;56:79–83PubMedGoogle Scholar
  10. 10.
    Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343–346PubMedGoogle Scholar
  11. 11.
    Lincoln SR, Long CA, Whitworth NS, Sopelak VM, Cowan BD: Elevated luteinizing hormone on the day of human chorionic gonadotropin administration does not reduce cycle fecundity in a low-dose flare-up in vitro fertilization protocol. Fertil Steril 1995;63:563–565PubMedGoogle Scholar
  12. 12.
    Paulson RJ, Sauer MV, Francis MM, Macaso TM, Lobo RA: In vitro fertilization in unstimulated cycles: A clinical trial using hCG for timing of follicle aspiration. Obstet Gynecol 1990;76:788–791PubMedGoogle Scholar
  13. 13.
    Foulot H, Ranoux C, Dubuisson J-B, Rambaud D, Aubriot F-X, Poirot C: In vitro fertilization without ovarian stimulation: A simplified protocol applied in 80 cycles. Fertil Steril 1989;52:617–621PubMedGoogle Scholar
  14. 14.
    Steinkampf MP, Kretzer PA, McElroy E, Conway-Meyers B-A: A simplified approach to in vitro fertilization. J Reprod Med 1992;37:199–204PubMedGoogle Scholar
  15. 15.
    Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G: Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552–556PubMedGoogle Scholar
  16. 16.
    Bentick B, Shaw RW, Iffland CA, Burford G, Bernard A: A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with buserelin for superovulation and in vitro fertilization. Fertil Steril 1988;50:79–84PubMedGoogle Scholar
  17. 17.
    Shoham Z, Jacobs HS, Insler V: Luteinizing hormone: Its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993;59:1153–1161PubMedGoogle Scholar
  18. 18.
    Conway GS, Honour JW, Jacobs HS: Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989;30:459–470Google Scholar
  19. 19.
    Regan L: The luteinizing hormone hypothesis—high follicular phase luteinizing hormones. Lessons from assisted conception and anovulatory infertility. Gonadotrophins, gonadotrophin-releasing hormone analogues and growth factors in infertility: Future perspective. Proceedings of a meeting held at the Royal Baths Assembly Room Harrogate, Yorkshire, UK, Apr 29–30, 1991Google Scholar
  20. 20.
    Stanger JD, Yovich JL: Reduced in-vitro fertilisation of human oocyte from patients with raised basal luteinising hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385–393PubMedGoogle Scholar
  21. 21.
    Givens CR, Schriock ED, Dandekar PV, Martin MC: Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011–1017PubMedGoogle Scholar
  22. 22.
    Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R: Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090–1094PubMedGoogle Scholar
  23. 23.
    Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS: Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797–803PubMedGoogle Scholar
  24. 24.
    Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ: Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;54:853–857PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Jeffrey L. Deaton
    • 1
  • Paula Bauguess
    • 1
  • Carolyn S. Huffman
    • 1
  • Kathleen A. Miller
    • 1
  1. 1.Section on Reproductive EndocrinologyBowman Gray School of Medicine of Wake Forest UniversityWinston-Salem

Personalised recommendations